FREE Case Review (866) 588-0600

Avelox Peripheral Neuropathy Lawsuit

In August 2013, the FDA issued a Drug Safety Communication stating that Avelox has the potential to cause peripheral neuropathy.

In August 2013, the U.S. Food & Drug Administration (FDA) issued a Drug Safety Communication stating that the antibiotic drug Avelox (generic: moxifloxacin) has the potential to cause peripheral neuropathy, a severe form of nerve damage that causes symptoms such as chronic nerve pain, muscle weakness, numbness, and problems with routine physical activities. 

Free Confidential Lawsuit Evaluation: If you or a loved one was diagnosed with peripheral neuropathy after taking Avelox, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

Update: Fluoroquinolone MDL Moving Forward in Minnesota

March 22, 2017Product liability lawsuits alleging peripheral neuropathy from Levaquin, Cipro and Avelox are moving forward in the U.S. District Court for the District of Minnesota, with at least 10 bellwether cases being prepped for trial. Per a recent update, there are at least 738 lawsuits pending in the fluoroquinolone multidistrict litigation (MDL No. 2642), most of which involve Levaquin.

Avelox Overview

Released by Bayer AG in 1999, Avelox is a ‘broad spectrum’ antibiotic medication designed to kill many different types of bacteria. The drug is typically prescribed to treat bacterial infections in adults. Specifically, Avelox is approved for the treatment of the following conditions:

  • Abdominal (stomach) infections
  • Bronchitis
  • Pneumonia
  • Skin infections
  • Sinus infections

In many cases, Avelox is prescribed to treat an infection while tests are being performed to determine what antibiotic medications are likely to be effective. If the test results indicate that a medication with a narrower spectrum will be more effective, your physician may change you to a regimen of that drug. This is intended to limit antibacterial resistance, since overuse of broad-spectrum medications can increase the risk of bacteria becoming resistant to antibiotics.

FDA Warning on Avelox & Peripheral Neuropathy (PN)

In August 2013, the FDA issued a Drug Safety Communication stating that it was requiring labels of Avelox and other fluoroquinolone medications to “better describe the serious side effect of peripheral neuropathy.” In certain patients, this condition has been found to occur soon after treatment with Avelox begins. PN is associated with oral and injectable fluoroquinolones, but not topical formulations that are applied to the eyes and ears.

Symptoms of Peripheral Neuropathy

Signs and symptoms of Avelox-induced peripheral neuropathy may include:

  • Pain
  • Burning
  • Tingling
  • Numbness
  • Weakness
  • Change in sensation to light touch, pain, or temperature
  • Change in sense of body position
  • Loss of reflexes
  • Paresthesia
  • Muscle wasting
  • Paralysis

Avelox Side Effects

In addition to having the potential to cause peripheral neuropathy, Avelox has also been linked to the following serious side effects:

  • Liver disorders
  • Stevens-Johnson Syndrome (SJS)
  • Muscle injuries
  • Tendon injuries

Additional Information About Avelox and Peripheral Neuropathy

Click on the links below if you’d like additional information about Avelox and peripheral neuropathy:

FDA Strengthens Avelox Warning Labels

July 26, 2016 – An FDA Drug Safety Communication issued today announced stronger label warnings for Avelox and other fluoroquinolone antibiotics because they may lead to disabling side effects, including long-term nerve damage and ruptured tendons. The agency also cautioned that the bacteria-fighting drugs shouldn’t be prescribed for sinusitis, chronic bronchitis or simple urinary tract infections (UTIs) unless patients have no other treatments options.

Do I Have an Avelox Peripheral Neuropathy Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Avelox lawsuits. We are handling individual litigation nationwide and currently accepting new Avelox peripheral neuropathy cases in all 50 states.

Free Confidential Case Evaluation: Again, if you developed peripheral neuropathy after taking Avelox, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition